secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001493152-24-013255
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma raises $10M in registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Sold 33,333,334 shares and warrants at $0.30/unit; gross proceeds ~$10M.
- Warrants exercisable at $0.35/share for 5.5 years from issuance, starting 6 months post-closing.
- Proceeds to be used for working capital and general corporate purposes.
- Offering expected to close April 5, 2024; A.G.P./Alliance Global Partners sole placement agent.
- Directors and officers subject to 90-day lock-up on securities transfers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224013255/0001493152-24-013255-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224013255/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-013255

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer